Although the exact pathophysiological contribution of OPG and OPN to peripheral atherosclerotic disease is yet to be elucidated, our findings suggest that OPG and OPN could serve as possible biomarkers of PAD progression/prognosis after endovascular revascularization. Here, TNFRSF11B is linked to peripheral arterial disease.